Greg Eriksen Tampa

Greg Eriksen is a successful sales executive within the medical device field. Since 2010, he has served the Florida market with Intuitive Surgical, a surgical equipment company based in Sunnyvale, California. In his current role as an Area Sales Manager, he works in concert with chief executives, administration, and surgeons, and for area hospitals, to develop, implement, or expand new and existing multispecialty robotic surgery programs in Central and North Florida. He is responsible for the Capital Sales of the da Vinci robotic surgical platform. This technology is utilized in various specialties including general and cardiothoracic surgery, urology, gynecologic oncology, and various emerging areas.

Greg Eriksen started with Intuitive, Inc. in 2010 as a Clinical Sales representative working with surgeons and staff to increase daily utilization of the da Vinci robot within the hospitals he was responsible for. He was responsible for training new surgeons on how to use the system and helping them integrate this surgical approach into their practice. In 2011 he was promoted to a Clinical Sales Trainer and helped train new clinical sales representatives for Intuitive Surgical within the southeast United States. A sales executive with over a decade of experience with a primary focus on medical device, Mr. Eriksen possesses a robust professional skill set. Throughout his career as a sales executive and sales trainer, he has applied expertise in marketing, account management, leadership, and medical technology.

Mr. Eriksen studied Finance and Marketing at the University of Florida's Warrington College of Business Administration. He gained early experience as a sales executive for the major pharmaceutical company Novartis Pharmaceuticals. In this capacity, he worked with cardiologists, gastroenterologists, and other physicians in promoting medications marketed for the treatment of hypertension and irritable bowel syndrome. Greg Eriksen also demonstrated continually excellent sales performance, which Novartis recognized with a number of awards. He later served as a sales executive for Alveolus Medical and helped to facilitate the adoption of surgical stents for use in patients suffering from respiratory and gastrointestinal constriction caused by malignant tumors. In this role, he also cooperated and trained surgeons in various specialties including surgical oncology, cardio-thoracic, gastroenterology, and re